Grants and Contributions:
Title:
Optimization of Breast Cancer Blood-based Diagnostic Test
Agreement Number:
907317
Agreement Value:
$237,852.00
Agreement Date:
May 1, 2018 - Mar 31, 2020
Description:
The project focuses on the clinical evaluation and validation of Syantra’s blood and tissue based breast cancer test. Software development and ICT related optimization, data analysis and reporting will also be finalized to support product's commerical use.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Calgary, Alberta, CA T2N 1N4
Reference Number:
172-2018-2019-Q1-907317
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
772728499
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 152 days.
Amendment Date
Dec 19, 2019
Recipient's Legal Name:
Syantra Inc.
Federal Riding Name:
Calgary Confederation
Federal Riding Number:
48005
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512
Amendments: